← Back to Search

Behavioural Intervention

Active stimulation for Depression

N/A

Waitlist Available

Research Sponsored by Flow Neuroscience AB

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 weeks

Awards & highlights

Study Summary

This trial is investigating whether or not a specific device (Flow FL-100 tDCS) is effective in treating major depressive disorder. The trial will be conducted with participants from two locations, Texas in the United States and England/Wales in the United Kingdom.

Eligible Conditions

Depression

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

HDRS-17

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Active stimulationActive Control1 Intervention

Active stimulation at 2mA

Group II: Sham stimulationPlacebo Group1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of TexasOTHER

187 Previous Clinical Trials

142,279 Total Patients Enrolled

11 Trials studying Depression

1,296 Patients Enrolled for Depression

Flow Neuroscience ABLead Sponsor

University of East LondonOTHER

10 Previous Clinical Trials

669 Total Patients Enrolled

2 Trials studying Depression

75 Patients Enrolled for Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being accepted for this clinical investigation?

"Affirmative. According to the data provided by clinicaltrials.gov, this medical trial is currently accepting participants and was published on May 1st of 2022. The latest update was posted 18 days later with a target enrollment of 270 from one site."

Answered by AI

Are there any vacancies available for participation in this experimental investigation?

"Per the data hosted on clinicaltrials.gov, this medical research is actively searching for participants. This trial was initially published on May 1st 2022 and last modified on May 18th of the same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Empower: tDCS for Major Depressive Disorder at Home

2022. "Empower: tDCS for Major Depressive Disorder at Home". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05202119.